Chemed (CHE) Total Non-Current Liabilities (2009 - 2026)

Chemed's Total Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $674.3 million for Q1 2026.

• In Q1 2026, Total Non-Current Liabilities rose 26.82% year-over-year to $674.3 million; the TTM figure through Mar 2026 stood at $674.3 million (up 26.82% YoY), while the FY2025 annual figure was $545.4 million, up 1.72% from the prior year.
• Total Non-Current Liabilities was $674.3 million for Q1 2026 at Chemed, up from $545.4 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $674.3 million in Q1 2026 to a low of $506.1 million in Q2 2025.
• Historically, Total Non-Current Liabilities has averaged $561.7 million across 5 years, with a median of $538.6 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities advanced 27.05% in 2022, then declined 14.97% in 2023.
• A 5-year view of Total Non-Current Liabilities shows it stood at $631.2 million in 2022, then retreated by 13.3% to $547.2 million in 2023, then slipped by 2.01% to $536.2 million in 2024, then grew by 1.72% to $545.4 million in 2025, then increased by 23.62% to $674.3 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $674.3 million (Q1 2026), $545.4 million (Q4 2025), and $533.6 million (Q3 2025), per Business Quant data.